AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.84
+0.20 (1.88%)
At close: Mar 31, 2025, 4:00 PM
10.86
+0.02 (0.17%)
After-hours: Mar 31, 2025, 6:18 PM EDT

Company Description

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 10,500
CEO Suzanne Foster

Contact Details

Address:
220 West Germantown Pike, Suite 250
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610 424 4515
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Suzanne M. Foster M.P.H. Chief Executive Officer and Director
Jason A. Clemens C.F.A. Chief Financial Officer
Albert A. Prast Chief Technology Officer
Scott Barnhart Chief Operating Officer
Christine E. Archbold Chief Accounting Officer
Nalin Narayanam Chief Information Officer
Wendy Russalesi Chief Compliance Officer
Richard W. Rew II Chief Legal Officer and General Counsel
Joel Mills Chief People Officer
Briah Carey President of Diabetes

Latest SEC Filings

Date Type Title
Feb 25, 2025 10-K Annual Report
Feb 25, 2025 8-K Current Report
Feb 13, 2025 SCHEDULE 13G/A Filing
Dec 19, 2024 144 Filing
Dec 13, 2024 8-K Current Report
Dec 10, 2024 144 Filing
Nov 22, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 144 Filing